Category: Uncategorized

Empowering Biotech Innovations: Cryometrix’s Liquid Nitrogen Storage Solutions

Posted on

In the rapidly evolving biotechnology sector, precise and reliable cryogenic cooling technologies are pivotal. Cryometrix, a leader in the industry, stands out with its patented liquid nitrogen-based cooling systems. These systems serve a broad spectrum of needs across biotechnology, pharmaceutical, and medical fields. This post delves into Cryometrix’s cutting-edge products and their transformative impacts on the industry.

Cryometrix’s Innovation and Patented Technologies

Cryometrix has firmly established itself as a leader in cryogenic technology through its innovative approach to liquid nitrogen utilization. The company holds more than 30 patents, a testament to its commitment to groundbreaking research and development. These patents cover a range of technologies, from advanced cooling systems that drastically reduce cooling times to safety mechanisms that prevent nitrogen exposure to both products and personnel.

The core of Cryometrix’s technology lies in its unique use of liquid nitrogen — a method that eschews traditional mechanical compressors in favor of a cleaner, more efficient cooling medium. This approach not only allows for rapid temperature reduction but also enhances the precision of temperature control, critical in sensitive biotech applications. By continuously refining their technology, Cryometrix ensures that their products remain at the cutting edge of the biotech industry’s needs, empowering researchers and manufacturers with tools that are both innovative and reliable.

Key Products and Their Impact

B-90 Blast/Thaw Freezer

  • Functionality: The B-90 quickly brings temperatures from 20°C down to -90°C in just 10 minutes. Its method involves cooled circulated air, which is chilled by liquid nitrogen, ensuring rapid freezing without direct exposure to the nitrogen itself.
  • Safety and Integrity: The design guarantees that neither the product nor personnel come into contact with liquid nitrogen, thereby maintaining high product quality and operational safety.
  • Specifications: Key features include excellent temperature uniformity, economic use of LN2, and a generous 20-year warranty covering cooling system parts.

MB-90 Chest Blast Freezer

  • Design and Efficiency: This compact freezer is perfect for laboratory settings and scalable to production environments. It allows for adjustable temperature profiles, which can be crucial for experimental and production flexibility.
  • Innovative Features: It shares several design principles with the larger B-90 model, ensuring consistency and quality in freezing processes.
  • Usage and Applications: Its adaptability makes it ideal for research facilities transitioning from development phases to full-scale production.

T-160 Ultra-Low Temperature Freezer

  • Advanced Cooling: Achieves ultra-low temperatures up to -160°C efficiently without the traditional mechanical compressors, reducing electricity consumption significantly.
  • Safety and Maintenance: Incorporates a fully contained LN2 system, enhancing user safety and virtually eliminating maintenance demands.
  • Environmental Benefits: The T-160 operates with clean emissions, releasing only nitrogen into the atmosphere, which is both safe and environmentally benign.

S-90 Low Temperature Shipper

  • Transport Capabilities: Designed for secure and stable transport of biotech products, the S-90 can maintain temperatures of -80°C for extended periods (up to 15 days), ideal for both domestic and international shipping.
  • Self-Sufficient Operation: Equipped with its own LN2 supply and battery power, it’s a robust solution for the logistical challenges faced by the biotech industry.
  • Product Safety: The advanced control system ensures temperature uniformity and integrity throughout the transportation process.

T-90 Storage Freezer

  • Efficient and Reliable: Provides precise temperature control and stability with minimal operational costs and energy consumption.
  • User and Environmental Safety: Like other Cryometrix models, it features a closed liquid nitrogen system for enhanced safety and minimal environmental impact.
  • Longevity and Maintenance: The design promises a long operational lifespan with little to no maintenance required, supported by a 20-year warranty.

MC-135 Chest Freezer

  • Compact and Secure: Tailored for smaller-scale applications, yet robust enough to reach -140°C rapidly with efficient LN2 usage.
  • Versatile Use: Its size and performance make it suitable for a variety of applications, including secure pharmaceutical storage.
  • High Performance: Demonstrates quick temperature recovery, low LN2 consumption, and consistent temperature maintenance.

Competitive Advantages of Cryometrix Products

Cryometrix’s products stand out in the marketplace for several compelling reasons:

  1. Unmatched Cooling Speed: Cryometrix freezers and shippers can achieve rapid cooling rates, significantly faster than traditional methods. This speed is crucial for applications requiring quick freeze methods to preserve the integrity and activity of biological samples, such as tissues, cells, and pharmaceuticals.
  2. Temperature Uniformity: One of the most critical factors in the storage of biotechnological materials is maintaining consistent temperature throughout the storage space. Cryometrix’s advanced airflow design and control technology ensure minimal temperature variation, which is vital for experimental consistency and regulatory compliance.
  3. Low Maintenance Costs: Without the mechanical components that typically wear down over time, such as compressors and HVAC systems, Cryometrix units are much less prone to breakdowns and require fewer repairs. This translates into lower operational costs over the lifespan of the products.
  4. Patented Liquid Nitrogen Technology: Utilizing liquid nitrogen not only provides superior cooling capabilities but also allows these systems to operate with a high degree of energy efficiency and reliability.
  5. No CFCs Used: In an era where environmental impact is increasingly scrutinized, Cryometrix’s commitment to using technologies that do not involve chlorofluorocarbons (CFCs) aligns with global efforts to protect the ozone layer and reduce greenhouse gas emissions.
  6. Electric Refrigeration Pumps: These pumps further enhance the efficiency and control of the cooling process, enabling precise temperature management without the high power and maintenance costs associated with traditional cooling methods.

Environmental and Safety Considerations

Cryometrix is not only pioneering in technology but also leading in environmental stewardship and safety. Their systems emit only nitrogen, which is non-toxic, abundant in the atmosphere, and does not contribute to greenhouse gas effects, unlike many traditional refrigerants. This approach significantly reduces the ecological footprint of their cooling systems.

From a safety perspective, Cryometrix’s technologies are designed with operator and product safety in mind. The closed systems ensure that there is no direct contact with liquid nitrogen, which can be hazardous. This design minimizes the risk of spills or leaks, which can lead to injuries or contamination of sensitive biological materials. Furthermore, the stainless steel construction of the freezers facilitates easy cleaning and decontamination, supporting stringent hygiene standards required in pharmaceutical and medical settings.

Additionally, Cryometrix’s focus on reducing energy consumption not only lowers operating costs but also lessens the demand on electrical infrastructure, which can be particularly beneficial in areas with limited resources or unstable power supplies. This efficiency, coupled with the reliability of liquid nitrogen technology, ensures that Cryometrix’s products can deliver high performance even in challenging conditions.

Applications in the Biotech Industry

Cryometrix’s cooling solutions are instrumental across various facets of the biotech industry. Their state-of-the-art products cater to essential processes including sample preservation, pharmaceutical manufacturing, and biological transportation, providing critical support in several key areas:

  1. Biorepository and Biobanking: Cryometrix freezers offer unparalleled precision in temperature management, making them ideal for storing biological samples such as DNA, RNA, tissues, and cells. These samples require strict cryogenic environments to maintain viability over long periods, essential for research and therapeutic applications.
  2. Pharmaceuticals: The pharmaceutical industry benefits greatly from Cryometrix’s rapid cooling technologies, especially in the production of temperature-sensitive medicines and vaccines. The ability to quickly reduce and precisely control temperatures ensures that these critical products are manufactured and stored according to strict regulatory standards.
  3. Transportation and Logistics: Cryometrix’s shipping containers and low-temperature shippers enable safe and efficient transport of medical and pharmaceutical products across global supply chains. These units maintain consistent temperatures, crucial for the integrity of products such as biologics, which are sensitive to temperature fluctuations.
  4. Extraction and Chemical Processing: Utilizing their cooling technology, Cryometrix supports the extraction and purification processes in the pharmaceutical and chemical industries, where maintaining low temperatures is crucial for the stability and yield of extracted compounds.
  5. Clinical Research: In clinical settings, reliable cryogenic storage is vital for the preservation of clinical samples and the success of clinical trials. Cryometrix’s technology ensures that these materials are stored under optimal conditions, facilitating accurate and reliable clinical research outcomes.

Cryometrix’s Future Impact on Biotech Innovation

Cryometrix is not just a product manufacturer; it is a pivotal technology partner in the biotech industry. With their cutting-edge liquid nitrogen storage solutions, they empower biotech innovations, enhancing the efficiency, safety, and sustainability of biotechnological processes. As the industry continues to evolve, Cryometrix’s commitment to innovation and environmental stewardship positions them as a leader ready to meet the future challenges of biotechnology. Their ongoing advancements in cryogenic technology are set to redefine industry standards, offering new possibilities for biotech companies around the world.

Innovations in Cryogenic Freezing: Applications and Technologies

Posted on

Cryogenic freezing is an advanced technology that utilizes extremely low temperatures, typically below -150°C (-238°F), to preserve and maintain the integrity of materials over extended periods. This technique is fundamental in industries where the stabilization of biological materials, chemicals, and electronic components is crucial for further use or study. The ability to cool and maintain substances at such low temperatures has opened up numerous possibilities in medicine, space exploration, and even data storage technologies, providing the backbone for innovations that were once thought impossible.

The significance of cryogenic freezing extends beyond mere preservation. It plays a critical role in enhancing the capabilities of various scientific fields, enabling researchers and industry professionals to achieve results with precision and reliability. As we delve into this article, we’ll explore how modern advancements in cryogenic technology continue to push the boundaries of what is achievable, fostering new discoveries and applications that impact our health, environment, and technological frontiers.

Historical Background

The roots of cryogenic freezing trace back to the late 19th century when scientists first liquefied gases such as oxygen and nitrogen, setting the foundation for modern cryogenics. These initial breakthroughs were followed by the development of the Collins cryostat in the mid-20th century, which used helium to reach temperatures near absolute zero, crucial for both scientific research and space exploration.

Further advances came with the adoption of liquid nitrogen as a refrigerant. Its ease of handling and non-toxic nature made it highly suitable for diverse applications, including medical research and food preservation. Over the years, these innovations have evolved into today’s sophisticated cryogenic technologies, featuring precise temperature controls and enhanced energy efficiency, demonstrating the significant progress from early experimental techniques to the advanced systems used today.

Current Innovations in Cryogenic Freezing Technologies

Cryogenic freezing technologies have undergone significant advancements, enhancing their utility across multiple industries. These innovations focus on improving efficiency, reliability, and applicability in various fields.

Advances in Cryogenic Equipment and Materials

The latest developments in cryogenic materials include the use of more efficient and environmentally friendly refrigerants and enhanced insulation materials that ensure minimal thermal leakage and greater energy efficiency. Companies like Cryometrix, leveraging over 30 patents, lead this innovation with their state-of-the-art freezers and cooling systems, which employ proprietary liquid nitrogen technology.

Breakthroughs in Automation and Control Systems

Automation in cryogenic systems has reached new heights with the integration of smart sensors and IoT technologies. These systems offer real-time monitoring and precise control, crucial for maintaining the integrity of sensitive materials across biotechnology and medical fields. Cryometrix’s products, for instance, feature touch screen interfaces and configurable control settings, enabling high levels of customizability and security for different operational needs.

Energy Efficiency Improvements

Modern cryogenic systems emphasize reduced energy consumption and sustainable operation. Innovations such as energy-efficient cooling methods and advanced heat recovery systems are becoming standard. Cryometrix exemplifies this shift, with their systems using up to 90% less energy than traditional mechanical freezers, which translates to significant cost savings and a reduced environmental impact.

Applications of Cryogenic Freezing

Cryogenic freezing is pivotal in many critical areas, reflecting its growing importance beyond traditional fields.

Medical and Pharmaceutical Industries

In the medical and pharmaceutical sectors, cryogenic freezing is indispensable for the preservation of biological samples and the cryopreservation of substances crucial for medical treatments. The technology ensures the longevity and stability of blood, tissue samples, and various biomolecules. Cryometrix’s technology ensures that pharmaceutical products maintain their efficacy with unparalleled cooling speeds and temperature consistency.

Space Exploration

The exploration of outer space relies heavily on cryogenic technologies to preserve food and other life-sustaining materials over long durations. These technologies also help in the experimental preservation of materials under the harsh conditions of outer space, simulating environments that could be encountered on other planets.

Electronics and Superconductors

Cryogenic freezing plays a critical role in the production of superconductors and the development of quantum computers. The ability to reach and maintain ultra-low temperatures is essential for the effective functioning of these technologies, allowing for superconductivity and vastly improved processing speeds.

Challenges and Future Directions

While the field of cryogenic freezing is advancing rapidly, several challenges remain that could define future directions for research and development.

Technical Challenges in Scaling and Operation

Scaling cryogenic technologies for widespread commercial use remains challenging, often due to the high costs and complexity of maintaining extreme temperatures. Furthermore, the operational challenges of ensuring consistent and reliable freezing across different environments and scales pose significant hurdles.

Future Research Areas and Potential Innovations

Future innovations may focus on integrating nano-technology to enhance the efficiency and effectiveness of cryogenic systems. Cross-industry applications, such as in the aerospace, food preservation, and semiconductor industries, could broaden the impact of cryogenic technologies. There is also significant potential for advancements in cryogenic storage solutions, where improved automation and energy efficiency could transform biobanking and medical sample preservation.

As we move forward, the field of cryogenic freezing is likely to see groundbreaking innovations that will further enhance its application and efficiency across a range of industries, continuing to push the boundaries of what is possible in both industrial and research settings.

The Future of Cryogenic Freezing Technologies

Cryogenic freezing continues to be a cornerstone of technological advancement across multiple industries. The ongoing enhancements in technology, exemplified by companies like Cryometrix, promise to expand its applications and effectiveness in the coming years.

For those engaged in industries reliant on cryogenic technology, staying updated on these advancements is crucial. Consider exploring more about companies like Cryometrix, which are at the forefront of cryogenic technology innovations, offering solutions that push the boundaries of what’s possible in biopreservation and beyond.

Laboratory Refrigeration Solutions: Ensuring Consistency and Reliability

Posted on

In today’s highly specialized fields of biotechnology, medical research, pharmaceuticals, extraction industries, and temperature-sensitive transportation, the precise preservation of biological samples, drugs, and other critical materials at exact temperatures is more than a routine requirement—it is an absolute imperative for the integrity of scientific outcomes and the safety of pharmaceutical products. Enter Cryometrix, a pioneering company at the forefront of laboratory refrigeration technology. With its foundation firmly rooted in the innovative application of over 30 patents related to the utilization of liquid nitrogen, Cryometrix offers a revolutionary approach to cryogenic cooling. This technological advancement has positioned the company as an industry leader, providing unparalleled refrigeration solutions designed to meet the rigorous demands of a wide array of sectors. Cryometrix’s product portfolio includes low-temperature freezers, rapid blast freezers, and ethanol chilling systems, each engineered with proprietary technology to deliver unmatched efficiency, reliability, and performance. These state-of-the-art solutions cater not only to the preservation and processing needs of vital materials but also embody the company’s commitment to innovation, superior quality, and the empowerment of customers across the globe to achieve optimal results in their respective fields.

The Cryometrix Advantage

Cryometrix’s unique approach to refrigeration solutions stems from its innovative use of liquid nitrogen technology, a hallmark that distinguishes its offerings in the market. This technology underpins a suite of advantages, making Cryometrix the go-to choice for industries requiring the highest standards of cooling efficiency and reliability. The core benefits include unparalleled cooling speeds, exceptional temperature uniformity across storage units, minimal maintenance requirements, and a steadfast commitment to environmental sustainability. Together, these features not only elevate the performance of Cryometrix’s products but also ensure they meet the evolving needs of critical sectors like biotechnology, pharmaceuticals, and medical research.

Unmatched Cooling Speed and Temperature Uniformity

Cryometrix’s products stand out for their ability to rapidly achieve and maintain precise temperatures, a critical factor in the preservation and transportation of sensitive materials. The integration of liquid nitrogen cooling technology enables these systems to reach target temperatures much faster than traditional methods. This rapid cooling is complemented by advanced design features ensuring temperature uniformity within the units, thereby eliminating hot spots that could compromise sample integrity. Such consistency is vital for critical applications, including the storage of high-value pharmaceuticals, where even slight variations in temperature can lead to significant losses.

Low Maintenance and Operational Costs

The durability and efficiency of Cryometrix’s refrigeration solutions translate into significantly lower operational and maintenance costs. By eschewing mechanical compressors in favor of liquid nitrogen, these units reduce the parts prone to wear and tear, thereby extending their lifespan and reducing the frequency of maintenance interventions. This design philosophy not only enhances reliability but also contributes to lower energy consumption, further driving down the total cost of ownership. The economic advantages are complemented by operational benefits, including the ability to operate in a wide range of ambient conditions without the need for additional cooling infrastructure.

Environmentally Friendly

Cryometrix’s dedication to sustainability is evident in every aspect of its product design and operational philosophy. The use of liquid nitrogen, a clean and abundant resource, as the primary coolant eliminates the need for harmful refrigerants that contribute to global warming and ozone depletion. Furthermore, the energy-efficient operation of these units reduces the carbon footprint of refrigeration processes, aligning with the environmental goals of the industries Cryometrix serves. This commitment to environmental stewardship is a testament to the company’s role as a responsible corporate citizen in the fight against climate change.

Innovative Product Range

Cryometrix’s product portfolio is a reflection of the company’s innovative spirit and commitment to meeting the diverse needs of its customers. Each product, from ultra-low temperature freezers to portable chilling units, is designed with precision, leveraging proprietary liquid nitrogen technology for optimal performance. This versatility allows Cryometrix to cater to a wide array of applications, from laboratory research to pharmaceutical manufacturing and beyond. The emphasis on innovation is also evident in the company’s continuous investment in research and development, ensuring that its products remain at the cutting edge of refrigeration technology.

Applications Beyond the Lab

Beyond their traditional use in laboratory settings, Cryometrix’s refrigeration solutions have found applications in a variety of industries, demonstrating their versatility and adaptability. The L-80 chiller, for instance, has revolutionized the CBD extraction process by providing precise temperature control, thus enhancing the purity and quality of the final product. The adaptability of Cryometrix’s technology also extends to research and development sectors, where precise temperature control is critical for the success of experiments and the preservation of samples.

Elevating Laboratory Standards with Cryometrix

At the heart of scientific innovation and critical research lies the imperative need for reliable and efficient preservation solutions. Cryometrix stands as a beacon in this landscape, offering groundbreaking laboratory refrigeration solutions that not only meet but exceed the demands of consistency, reliability, and efficiency. With a product range built upon a foundation of over 30 patents in liquid nitrogen technology, Cryometrix is not merely a provider of refrigeration units; it is a partner in progress, enabling breakthroughs in biotechnology, pharmaceuticals, medical research, and beyond.

The ethos of Cryometrix is rooted in the pursuit of excellence and innovation. Each freezer, chiller, and transportation unit is a testament to the company’s commitment to providing state-of-the-art cryogenic cooling technologies. This commitment extends beyond the products themselves to embody a vision for a more sustainable and efficient future. By eschewing traditional refrigerants in favor of clean, nitrogen-based cooling, Cryometrix not only addresses the environmental concerns associated with CFCs but also offers solutions that are both energy-efficient and cost-effective.

The versatility of Cryometrix’s product line underscores its understanding of the diverse needs within the scientific and industrial communities. Whether it’s the precision required in CBD oil extraction, the rigor of pharmaceutical transport, or the demands of biorepository management, Cryometrix delivers unparalleled performance. Its technology ensures that every sample, no matter how sensitive, is preserved under optimal conditions, safeguarding the integrity of vital research and products.

Cryometrix’s innovations go beyond the lab, impacting industries and research fields by enabling more efficient processes, reducing operational costs, and promoting environmental sustainability. The company’s forward-thinking approach to refrigeration challenges the status quo, setting new benchmarks for what is possible in cooling technology.

In conclusion, Cryometrix is reshaping the landscape of laboratory refrigeration solutions with its unwavering commitment to innovation, quality, and sustainability. By choosing Cryometrix, researchers, and industry professionals not only gain access to the pinnacle of cryogenic cooling technology but also become part of a movement towards more responsible and efficient scientific exploration. Explore the future of laboratory refrigeration with Cryometrix, and experience the difference that true innovation can make in preserving and processing the materials that drive our world forward. Contact us today to learn how their solutions can elevate your operations to new heights.

Optimizing Pharmaceutical Storage: The Role of Advanced Freezers

Posted on

Pharmaceutical storage is a critical component in the healthcare industry. It’s not just about keeping products cold; it’s about ensuring that medicines, vaccines, and biological materials maintain their integrity, efficacy, and safety from production to delivery. With advancements in technology, the approach to pharmaceutical storage has evolved significantly, leading to enhanced preservation methods and optimized storage solutions.

The Importance of Precision in Pharmaceutical Storage

The storage of pharmaceutical products demands precision and care due to several critical factors:

  1. Temperature Sensitivity: Many pharmaceuticals, especially biologics and vaccines, have a narrow temperature range within which they remain stable and effective. Even minor fluctuations can lead to degradation of the active ingredients, reducing their efficacy or even rendering them unsafe for use.
  2. Regulatory Compliance: The pharmaceutical industry is subject to strict regulations from bodies like the FDA and EMA. These agencies set stringent guidelines for the storage and handling of pharmaceutical products to ensure patient safety. Non-compliance can result in severe consequences, including product recalls, legal penalties, and damage to the manufacturer’s reputation.
  3. Product Longevity and Efficacy: Proper storage conditions extend the shelf life of pharmaceutical products, ensuring they remain effective until their expiration date. This is not only important for patient safety but also for the economic viability of pharmaceutical companies. Effective storage reduces waste caused by spoiled products, ensuring a steady supply to meet market demands.
  4. Diverse Storage Requirements: Different pharmaceuticals require different storage conditions. For instance, some vaccines need ultra-cold storage at temperatures as low as -70°C, while others may require refrigeration or ambient conditions. This diversity necessitates a range of storage solutions capable of meeting varied requirements.
  5. Global Distribution Challenges: With the global distribution of pharmaceutical products, ensuring that the cold chain is maintained from the point of manufacture to the point of use is a complex logistical challenge. Breaks in the cold chain can compromise product quality and patient safety.

Advanced Freezing Technologies: A Game Changer

The advent of advanced freezing technologies marks a significant milestone in pharmaceutical storage. These sophisticated systems bring several transformative benefits to the industry:

  • Ultra-Precise Temperature Control: Unlike traditional freezers, advanced systems provide exact temperature regulation. This precision is crucial for storing sensitive pharmaceuticals, where even minor temperature fluctuations can lead to product degradation.
  • Rapid Temperature Adjustment: Advanced freezers can quickly reach the desired low temperatures, which is vital for the swift preservation of heat-sensitive materials immediately after production.
  • Enhanced Energy Efficiency: Modern freezing technologies are designed to be more energy-efficient compared to traditional methods. This not only reduces operational costs but also supports environmental sustainability initiatives within the pharmaceutical industry.
  • Customizable Storage Conditions: These freezers often come with customizable settings, allowing for specific temperature and humidity conditions tailored to different types of pharmaceutical products.
  • Improved Safety Features: Advanced freezers include features like alarm systems, backup power options, and temperature logging, ensuring product safety and regulatory compliance.
  • Space Optimization: Modern designs tend to have a smaller footprint, maximizing storage capacity and efficiency in limited laboratory or storage spaces.

These technological advancements in freezing not only enhance the storage quality but also contribute to the overall reliability and efficiency of pharmaceutical logistics, from manufacturing to distribution.

Liquid Nitrogen: The Backbone of Modern Storage

Liquid nitrogen (LN2) is increasingly becoming the cornerstone of advanced pharmaceutical storage for several compelling reasons:

  • Ultra-Low Temperatures: LN2 has a boiling point of -196°C, allowing freezers to reach and maintain extremely low temperatures essential for preserving sensitive pharmaceuticals.
  • Rapid Cooling: This technology enables quick cooling, vital for materials that might degrade if not rapidly brought to the required low temperature.
  • Enhanced Stability: LN2 provides consistent cooling, crucial for maintaining the integrity of temperature-sensitive materials over extended periods.
  • Environmentally Friendly: With no harmful refrigerants like CFCs, LN2 is a greener choice, aligning with global environmental sustainability goals.
  • Energy Efficiency: LN2 freezers typically consume less energy compared to traditional refrigeration methods. This not only lowers operating costs but also reduces the carbon footprint.
  • Safety: Unlike some refrigerants used in conventional freezers, LN2 is non-flammable and non-toxic, offering a safer alternative for both the storage facility and the environment.
  • Versatility: Liquid nitrogen can be used in a variety of freezer types, from small-scale laboratory freezers to large industrial units, making it a versatile solution for different needs in pharmaceutical storage.

The Broader Impact on Pharmaceutical Logistics

The integration of advanced freezing technologies has far-reaching implications in the pharmaceutical supply chain. This impact is felt in several key areas:

  • Transportation and Distribution: With products often needing to be transported over long distances, maintaining the required cold chain during transit is crucial. Advanced freezers enable safe transportation of temperature-sensitive pharmaceuticals, ensuring they remain effective upon reaching their destination.
  • Global Reach: Advanced storage solutions expand the reach of pharmaceutical companies, allowing them to distribute products globally while maintaining quality. This is particularly important for vaccines and biologics that require strict temperature control.
  • Emergency Response: In emergency situations, such as epidemics or natural disasters, the ability to quickly and reliably transport pharmaceutical products can be life-saving. Advanced freezing technologies play a vital role in these scenarios, ensuring medications reach those in need in optimal condition.
  • Cost Management: Efficient logistics reduce waste and associated costs. By maintaining the integrity of pharmaceutical products throughout the supply chain, companies can avoid the financial losses associated with product spoilage.
  • Compliance and Traceability: Advanced freezers with data-logging capabilities help in maintaining detailed records of storage conditions throughout the supply chain, aiding in regulatory compliance and traceability.

Cryometrix Freezers: Enhancing Pharmaceutical Storage

Cryometrix freezers represent a significant leap in pharmaceutical storage technology. Their advanced freezers, such as the T-90 Storage Freezer and T-160 Ultra Low Freezer, offer specific benefits:

  • Rapid Temperature Attainment: Achieving desired temperatures quickly, crucial for sensitive materials.
  • Uniform Temperature Distribution: Ensuring the integrity of stored pharmaceuticals.
  • Reduced Energy Consumption: Offering an eco-friendlier and cost-effective solution.
  • Minimal Maintenance: Due to the absence of mechanical compressors, these freezers require less upkeep, translating to lower long-term costs.
  • Safety and Compliance: Meeting stringent industry regulations and ensuring the safety of stored products.

The integration of Cryometrix’s liquid nitrogen technology in their freezers adds another layer of efficiency and reliability, making these freezers a prime choice for pharmaceutical companies looking for top-tier storage solutions.

Challenges and Opportunities

While technology has advanced, challenges remain. These include managing the cost of high-tech storage solutions and ensuring that facilities worldwide can access and implement these technologies. However, these challenges also present opportunities for innovation and development in the field.

Forward-Thinking: Securing the Future of Pharmaceuticals

The optimization of pharmaceutical storage is not just about embracing current technological advancements; it’s a forward-thinking approach to ensuring public health and safety. As the pharmaceutical industry continues to evolve, the methods and technologies used for storage must not only keep pace but also anticipate future needs. Investments in advanced storage solutions like those offered by Cryometrix are crucial in ensuring that life-saving drugs and vaccines are preserved effectively and reach those in need safely and reliably. This commitment to innovation and quality in pharmaceutical storage is essential for the well-being of people around the world, today and in the future.

Exploring Liquid Nitrogen Freezers: A Guide for Lab Managers

Posted on

In the fast-evolving world of biotechnology, pharmaceuticals, and medical research, preserving and processing vital materials with maximum efficiency and reliability is paramount. This is where the innovative solutions from Cryometrix come into play, offering lab managers a groundbreaking approach to cryogenic cooling.

The Cryometrix Edge

Foundation of Patented Innovation

Cryometrix’s edge in the market is deeply rooted in its extensive patent portfolio, featuring over 30 patents specifically related to the use of liquid nitrogen. This rich foundation of intellectual property is not just a testament to their commitment to innovation but also a beacon of their expertise in cryogenic technology. It’s this core competency that allows Cryometrix to develop state-of-the-art freezers and chilling systems that cater to a wide array of industries, including biotechnology, medical, pharmaceutical, extraction, and transportation.

Advanced Cryogenic Solutions

At the heart of Cryometrix’s products is the use of proprietary liquid nitrogen technology. Unlike traditional refrigeration methods that rely on mechanical compressors and harmful CFCs, Cryometrix’s approach harnesses the power of liquid nitrogen for cooling. This method is not only more environmentally friendly but also more efficient in terms of energy usage. The cutting-edge application of this technology ensures that high-value pharmaceutical products, which require stringent cold conditions during transportation, are adequately preserved.

Competitive Advantages: A Deeper Dive

Cryometrix’s competitive edge can be attributed to several key factors:

  • Unmatched Cooling Speed: The use of liquid nitrogen enables rapid cooling, significantly faster than conventional methods. This feature is particularly crucial in situations where the quick freezing of biological samples or pharmaceuticals is essential to maintain their integrity.
  • Temperature Uniformity: The ability to maintain a consistent temperature throughout the storage space is vital, especially for sensitive materials. Cryometrix’s technology ensures uniform temperature distribution, minimizing the risk of sample degradation due to temperature fluctuations.
  • Low Maintenance and Operational Costs: The design of Cryometrix freezers minimizes moving parts, significantly reducing the wear and tear that typically leads to maintenance. This aspect, combined with the energy efficiency of liquid nitrogen cooling, results in substantially lower operational costs compared to traditional freezers.
  • Patented Technology and Environmental Responsibility: The patented liquid nitrogen technology not only sets Cryometrix apart in terms of performance but also reflects their commitment to sustainability. By eliminating the use of CFCs and reducing electricity consumption, Cryometrix aligns with environmentally responsible practices.
  • Electric Refrigeration Pumps: These pumps enhance the efficiency and reliability of the cooling process, further distinguishing Cryometrix’s products in the marketplace.
  • Space Efficiency and User-Friendly Design: The compact design of Cryometrix freezers ensures they occupy minimal floor space, a valuable attribute in space-constrained labs. Additionally, the upright design of these freezers facilitates easy access, simplifying the process of storing and retrieving samples.

Technological Superiority

Cryometrix’s technological edge is defined by its innovative use of liquid nitrogen, setting a new standard in the realm of cryogenic cooling. Here’s an in-depth look at what sets these freezers apart:

Revolutionary Liquid Nitrogen Technology

Unlike traditional freezers that rely on mechanical compressors using refrigerants like Freon, Cryometrix freezers employ a next-generation liquid nitrogen (LN2) technology. This method is not only quieter but significantly reduces electricity consumption, operating with seven times less energy than comparable lab freezers.

Low Energy Usage and Reliability

Cryometrix freezers stand out for their minimal energy requirements. The LN2 operates purely on pressure, eliminating the need for electricity to maintain cooling. This unique feature allows the freezers to function even in emergency situations where power is unavailable. Additionally, the absence of mechanical compressors means there are hardly any moving parts, drastically reducing the likelihood of mechanical failures and extending the lifespan of the freezers up to four times longer than traditional models.

Ambient Operation and Easy Expansion

An extraordinary aspect of Cryometrix freezers is their ability to operate in any ambient environment without the need for additional HVAC cooling. This capability not only simplifies installation but also enhances the flexibility of placing these units in various laboratory settings. Due to their low electricity consumption, adding more units to a facility is straightforward, without the usual electrical complications. With an effective footprint of less than 8 square feet and minimal side clearance requirements, these freezers easily integrate into existing spaces.

Versatility in Freezing

Conventional blast freezers often restrict usage to flat and thin objects due to their reliance on metal plates for freezing. In contrast, the B-90 Blast Freezer from Cryometrix utilizes liquid nitrogen efficiently, enabling the freezing of a wide range of items, regardless of their shape or size. This versatility is crucial for labs handling diverse types of biological samples or pharmaceutical products.

Long-Term Warranty and Sustainability

Cryometrix demonstrates confidence in its technology by offering a 20-year warranty on their freezer cooling systems. This long-term commitment underscores both the durability and the sustainable design of their products. By emitting only nitrogen, which is a major component of Earth’s atmosphere, these freezers align with environmentally friendly practices.

Safety and Sample Integrity

The safety and integrity of samples are of utmost importance in laboratory settings, particularly when dealing with sensitive biological, pharmaceutical, or chemical materials. Cryometrix’s liquid nitrogen freezers excel in this domain by incorporating advanced features and design elements that prioritize both operator safety and the preservation of sample integrity.

Advanced Closed Nitrogen System

  1. Zero Contact with LN2: The closed system design ensures that liquid nitrogen does not come into contact with the operator or the samples, significantly reducing the risk of contamination or accidental exposure.
  2. Autonomous LN2 Storage: The storage of LN2 is designed to be completely self-contained and autonomous, minimizing the need for constant monitoring and manual intervention.

Safety in Design

  1. Non-Flammable and Non-Explosive: Unlike many refrigerants used in compressor-based technologies, nitrogen is neither flammable nor explosive, reducing the risk of accidents in the laboratory.
  2. Ease of Cleaning: The interior and exterior of the freezer, made entirely of stainless steel, are designed for easy cleaning without the need for harsh industrial chemicals. This not only maintains a safer environment but also protects the integrity of stored samples.

Maintaining Sample Integrity

  1. Self-Contained Cooling System: The design ensures that no LN2 is exposed to the sample, maintaining the samples’ integrity and preventing cross-contamination.
  2. Data-Logging Capability: Cryometrix freezers are equipped with automatic data-logging features, enabling precise tracking of temperature and other vital parameters. This feature is crucial for ensuring the integrity of samples over time and facilitating compliance with various regulatory standards.
  3. Emergency Valve for Power Outages: The inclusion of redundant manual valves is a critical feature. In the event of a power outage, these valves can maintain the temperature in the payload bay, ensuring that the samples remain at the required conditions.
  4. Temperature Uniformity: The freezers are designed with multiple fans that create a high flux of airflow, ensuring uniform temperature distribution within the payload bay. This uniformity is vital for preventing the degradation of samples and ensuring consistent results in experiments and analyses.

Comprehensive Warranty and Support

Cryometrix’s commitment to safety and sample integrity is further reinforced by their comprehensive 20-year warranty on cooling systems. This warranty not only underscores the durability and reliability of their products but also provides lab managers with peace of mind, knowing that their investment is protected.

In Summary

Cryometrix’s liquid nitrogen freezers represent a leap in cryogenic cooling technology. Their products offer lab managers a host of advantages from unmatched cooling speed, low maintenance costs, to environmental friendliness and complete safety. This makes Cryometrix an ideal choice for those looking to optimize their biorepository needs with cutting-edge technology.

Explore more about Cryometrix and their innovative solutions at Cryometrix.com.

Cryometrix at the 2024 American Biomanufacturing Summit

Posted on

April 10-11, 2024 – Hyatt Regency San Francisco Airport


A New Era in Biomanufacturing with Cryometrix

As the prestigious American Biomanufacturing Summit celebrates its 10th Anniversary, Cryometrix is set to be a highlight, showcasing its innovative cryogenic technology to industry experts and leaders. With a robust portfolio of over 30 patents, Cryometrix’s liquid nitrogen technology is a game-changer in cryogenic cooling and freezing, offering unparalleled benefits to the biotechnology, medical, and pharmaceutical industries.

Showcasing Advanced Cryogenic Solutions

Cryometrix’s display at the American Biomanufacturing Summit will showcase its innovative cryogenic technology that stands out in energy efficiency, reliability, and environmental friendliness. Their cutting-edge products, like the B-90 Blast/Thaw Freezer and T-160 Ultra Low Freezer, represent a leap in cryogenic cooling, using next-gen liquid nitrogen technology that eschews traditional mechanical compressors. This approach not only reduces energy consumption — using 7x less electricity than standard lab freezers — but also enhances operational reliability and safety.

Key to their design is the use of liquid nitrogen, which operates independently of electricity, ensuring functionality even in power outages. With minimal moving parts, these freezers are incredibly durable, lasting up to four times longer than traditional models with little maintenance. Compact and versatile, Cryometrix’s freezers fit seamlessly into various settings, accommodating diverse biomanufacturing needs.

The environmental impact of these innovations is significant. Cryometrix freezers emit only nitrogen, vastly reducing the carbon footprint and aligning with global sustainability goals. Their commitment to green technology is further reflected in their 20-year warranty, ensuring long-term, eco-friendly operation.

This blend of efficiency, reliability, and environmental stewardship positions Cryometrix as a leader in cryogenic solutions, perfectly aligning with the summit’s themes of operational excellence, sustainability, and innovation in biomanufacturing.

Integration with Summit Themes

The themes of the 2024 summit resonate with Cryometrix’s mission and technology. The summit focuses on manufacturing agility, operational excellence, and regulatory compliance, areas where Cryometrix’s patented technologies offer compelling advantages. Their solutions, particularly in the realm of digital transformation and quality assurance, align with the industry’s shift towards more sustainable, efficient, and compliant practices.

Revolutionizing Biomanufacturing Processes

Cryometrix’s participation is more than a product showcase; it’s a contribution to the future of biomanufacturing. Their unique technology facilitates faster, more reliable, and eco-friendly cooling and freezing solutions. This plays a crucial role in addressing current challenges in biopharma manufacturing, such as the need for rapid scale-up, stringent quality controls, and efficient supply chain management.

A Hub for Networking and Collaboration

The American Biomanufacturing Summit provides an ideal platform for Cryometrix to network with over 150 industry leaders. It’s an opportunity to exchange ideas, share strategic insights, and explore collaborations that could shape the future of biomanufacturing. Cryometrix is positioned not just as a solution provider but also as a thought leader in this evolving field.

Educational Sessions and Workshops

Cryometrix will be participating in various educational sessions and workshops during the summit. These sessions will cover topics such as the role of cryogenic technology in enhancing quality metrics, strategies for effective supply chain management using advanced cooling systems, and the integration of Cryometrix’s technology in creating flexible, automated manufacturing facilities.

A Commitment to Sustainability and Efficiency

A key aspect of Cryometrix’s presentation will be its commitment to sustainability. Their products, utilizing patented liquid nitrogen technology, offer a greener alternative to traditional cooling methods, with no CFC emissions and significantly lower energy usage. This aligns with the global push towards more environmentally responsible manufacturing practices.

Looking Ahead: Cryometrix’s Vision for the Future of Biomanufacturing

The 2024 American Biomanufacturing Summit is an unmissable event for those in the biopharma sector, and Cryometrix’s presence promises to be one of its highlights. By offering advanced cryogenic solutions, Cryometrix is not only showcasing its technological prowess but also reinforcing its role as a catalyst for innovation and sustainability in biomanufacturing.

Discover more about Cryometrix and their revolutionary products by visiting Cryometrix.com. Join us at the Hyatt Regency San Francisco Airport for this landmark event and experience the future of biomanufacturing technology firsthand with Cryometrix.

Liquid Nitrogen Freezers Prove to be Game Changer for Pharma Industry

Posted on

Unlike compressor-based systems and cryovats, liquid nitrogen freezers safely deliver temperature-controlled freezing down to -160°C in minutes to preserve drug products, active ingredients, and biological samples

For decades, the pharmaceutical industry has relied on compressor-based systems to freeze drug products, active ingredients, vaccines, protein biologics, and biospecimens in all phases from research and development to storage, transport, and manufacturing.

Unfortunately, traditional mechanical freezers are limited in significant aspects. Compressors are known to break down frequently and require constant maintenance. Cooling and electrical requirements are high. These systems also utilize refrigerant, which limits cooling to approximately -100°C and is known to have a negative impact on the environment. Compressor-based systems also take considerable time to reach the desired temperature, which can lead to cryoconcentration, damage protein structures, degrade active ingredients, and reduce potency.

More recently, liquid nitrogen (LN2) cryovats have been utilized for faster freezing at cryogenic temperatures below -150°C. However, because the liquid nitrogen is not contained, there is some risk of exposure for technicians. Controlling temperature in vats is also difficult, even impossible, since there is no safe, reliable means of adjusting the temperature of the LN2 within the vat.

Now a game changing technology in the form of liquid nitrogen cryogenic freezers combines the best features of compressor-based systems and cryovats, but without the limitations.

Liquid nitrogen freezers circulate contained LN2 within their walls for safe, fast freezing down to -160°C. The units provide the convenience of an upright freezer with sophisticated temperature controls. By eliminating the need for compressors, liquid nitrogen freezers require much less maintenance or replacement, less energy, and are more eco-friendly since refrigerant is not required.

“Liquid nitrogen freezers cool faster because LN2 has a boiling point of -196°C, enabling units [using it] to cool to temperatures as low as -196°C. Most refrigerants have boiling points higher than -100°C, making it difficult for compressor-based freezers [using refrigerants] to operate at temperatures below that. Since the LN2 is self-contained, there is no exposure to the user or products,” says Kim Boyce, President of Reflect Scientific, Inc. (symbol: RSCF), an Orem, Utah-based manufacturer that develops and markets innovative, proprietary cryogenic cooling technologies for the pharmaceutical, biotechnology, medical, and transportation markets. The company has more than 30 patents relating to the use of liquid nitrogen with low-temperature freezers, chillers, and refrigerated systems.

According to Boyce, advanced LN2 freezers are available for the pharmaceutical industry in a variety of configurations and models, under the Cryometrix brand.

Upright LN2 freezers

Upright liquid nitrogen freezers provide adjustable temperatures from +20°C to -160°C. This is considerably lower than conventional upright freezer options, enabling significantly faster freeze times.

LN2 freezers minimize the risk of sample warming and quality deterioration due to door open-close events and offer one of the fastest recovery times in the industry. To safeguard sample integrity, state-of-the-art temperature and data logging can be easily accessed, and multiple security levels set. A redundant cooling system and onboard 7-day battery backup further ensure that processes can continue uninterrupted even upon loss of power.

The approach also uses up to 90% less energy than mechanical, compressor-based units, which significantly reduces operating costs. Unlike compressor-based systems, no heat is exhausted to the room, eliminating the need for expensive HVAC systems for cooling. The freezer has a small footprint that suits space-constrained storage environments.

Pharmaceutical Case Use: Biorepositories

In the pharmaceutical and medical industries, liquid nitrogen freezers are utilized as biorepositories for the long-term collection, cataloging, and preservation of biospecimens such as tissue, cells, DNA, protein, blood, plasma, or urine. These biorepositories are essentially “libraries” where biospecimens are stored for clinical or research purposes.

Biorepositories are vital for understanding diseases, genetics, developing prophylactic and therapeutic agents, and monitoring human population health including outcomes related to environmental exposures.

LN2 Blast Freezers:

Advanced LN2 blast freezers can reliably lower the temperature of pharmaceutical and biological products to as much as -90°C in minutes with a greatly reduced risk of sample damage and significantly increased production throughput.

As an option, blast freezers can be designed to “do double duty” by rapidly thawing product when required using one machine. This can streamline throughput and eliminate the need for separate freezing and thawing equipment.

Pharmaceutical Case Use: Drug substances, vaccines, protein biologics, blood plasma

LN2 blast freezers are used to slow the rate of active-ingredient degradation of drug substances, vaccines, and protein biologics during storage.

For pharmaceutical research and at blood banks, blast freezers are used to rapidly freeze and store a range of thermally sensitive products such as blood plasma and cryoprecipitate. How quickly various blood plasma products are processed and frozen can affect the value and type of product produced, and even its viability.

Mini LN2 Blast Freezers

As the name indicates, mini LN2 blast freezers are smaller benchtop versions for pharmaceutical use where very quick freezing is necessary in a constrained space. Using only a small amount of LN2 from a portable dewar tank, these systems can cool from 20°C to -80°C in under two minutes. The temperature is adjustable from +40°C to -90°C.

Pharmaceutical Case Use: R&D, limited production

Pharmaceutical manufacturers use mini LN2 blast freezers to rapidly freeze and thaw thermally sensitive materials in the R&D phase for new drugs, vaccines, and biological products. It is important to establish the temperature profile of these materials to determine how products will respond to expected temperature fluctuations during transport, storage, and distribution. The compact units can simplify testing with temperature profile recipes to further expedite R&D, quality control, and even low-volume production.

The pharmaceutical industry has long used conventional compressor-based freezers and cryovats while tolerating the limitations. Now liquid nitrogen freezers are proving to be safer, faster, more reliable, eco-friendly alternatives that enable superior temperature control with less maintenance and energy use.

For more information: call 801-226-4100; email info@cryometrix.com; visit www.cryometrix.com; or write to the Cryometrix brand at Reflect Scientific, Inc., 1266 South 1380 West, Orem, Utah 84058.

Liquid Nitrogen Freezers a Game Changer for Pharma Industry

Posted on

Unlike compressor-based systems and cryovats, liquid nitrogen freezers safely deliver temperature-controlled freezing down to -160°C in minutes to preserve drug products, active ingredients and biological samples.

For decades, the pharmaceutical industry has relied on compressor-based systems to freeze drug products, active ingredients, vaccines, protein biologics and biospecimens in all phases from research and development to storage, transport and manufacturing.

Unfortunately, traditional mechanical freezers are limited in significant aspects. Compressors are known to break down frequently and require constant maintenance. Cooling and electrical requirements are high. These systems also utilise refrigerant, which limits cooling to approximately -100°C and is known to have a negative impact on the environment. Compressor-based systems also take considerable time to reach the desired temperature, which can lead to cryoconcentration, damage protein structures, degrade active ingredients and reduce potency.

More recently, liquid nitrogen (LN2) cryovats have been utilised for faster freezing at cryogenic temperatures below -150°C. However, because the liquid nitrogen is not contained, there is some risk of exposure for technicians. Controlling temperature in vats is also difficult, even impossible, since there is no safe, reliable means of adjusting the temperature of the LN2 within the vat.

Now, a game-changing technology in the form of liquid nitrogen cryogenic freezers combines the best features of compressor-based systems and cryovats, but without the limitations.

Liquid nitrogen freezers circulate contained LN2 within their walls for safe, fast freezing down to -160°C. The units provide the convenience of an upright freezer with sophisticated temperature controls. By eliminating the need for compressors, liquid nitrogen freezers require much less maintenance or replacement, use less energy, and are more eco-friendly since refrigerant is not required.

“Liquid nitrogen freezers cool faster because LN2 has a boiling point of -196°C, enabling units [using it] to cool to temperatures as low as -196°C,” said Kim Boyce, President of Reflect Scientific. “Most refrigerants have boiling points higher than -100°C, making it difficult for compressor-based freezers [using refrigerants] to operate at temperatures below that. Since the LN2 is self-contained, there is no exposure to the user or products.”

Advanced LN2 freezers are available for the pharmaceutical industry in a variety of configurations and models, under Reflect Scientific’s Cryometrix brand.

Upright LN2 freezers

Upright liquid nitrogen freezers provide adjustable temperatures from +20 to -160°C. This is considerably lower than conventional upright freezer options, enabling significantly faster freeze times.

LN2 freezers minimise the risk of sample warming and quality deterioration due to door open-close events and offer one of the fastest recovery times in the industry. To safeguard sample integrity, state-of-the-art temperature and data logging can be easily accessed, and multiple security levels set. A redundant cooling system and onboard seven-day battery backup further ensure that processes can continue uninterrupted even upon loss of power.

The approach also uses up to 90% less energy than mechanical, compressor-based units, which significantly reduces operating costs. Unlike compressor-based systems, no heat is exhausted to the room, eliminating the need for expensive HVAC systems for cooling. The freezer has a small footprint that suits space-constrained storage environments.

Pharmaceutical use case: biorepositories

In the pharmaceutical and medical industries, liquid nitrogen freezers are utilised as biorepositories for the long-term collection, cataloguing and preservation of biospecimens such as tissue, cells, DNA, protein, blood, plasma or urine. These biorepositories are essentially ‘libraries’ where biospecimens are stored for clinical or research purposes.

Biorepositories are vital for understanding diseases and genetics, developing prophylactic and therapeutic agents, and monitoring human population health including outcomes related to environmental exposures.

LN2 blast freezers

Advanced LN2 blast freezers can reliably lower the temperature of pharmaceutical and biological products to as much as -90°C in minutes with a greatly reduced risk of sample damage and significantly increased production throughput.

As an option, blast freezers can be designed to do ‘double duty’ by rapidly thawing product when required using one machine. This can streamline throughput and eliminate the need for separate freezing and thawing equipment.

Pharmaceutical use case: drug substances, vaccines, protein biologics, blood plasma

LN2 blast freezers are used to slow the rate of active-ingredient degradation of drug substances, vaccines, and protein biologics during storage.

For pharmaceutical research and at blood banks, blast freezers are used to rapidly freeze and store a range of thermally sensitive products such as blood plasma and cryoprecipitate. How quickly various blood plasma products are processed and frozen can affect the value and type of product produced, and even its viability.

Mini LN2 blast freezers

As the name indicates, mini LN2 blast freezers are smaller benchtop versions for pharmaceutical use where very quick freezing is necessary in a constrained space. Using only a small amount of LN2 from a portable dewar tank, these systems can cool from +20 to -80°C in under two minutes. The temperature is adjustable from +40 to -90°C.

Pharmaceutical use case: R&D, limited production

Pharmaceutical manufacturers use mini LN2 blast freezers to rapidly freeze and thaw thermally sensitive materials in the R&D phase for new drugs, vaccines and biological products. It is important to establish the temperature profile of these materials to determine how products will respond to expected temperature fluctuations during transport, storage and distribution. The compact units can simplify testing with temperature profile recipes to further expedite R&D, quality control and even low-volume production.

The pharmaceutical industry has long used conventional compressor-based freezers and cryovats while tolerating the limitations. Now liquid nitrogen freezers are proving to be safer, faster, more reliable, eco-friendly alternatives that enable superior temperature control with less maintenance and energy use.

*Del Williams is a technical writer based in Torrance, California.

Test Drive State-of-the-Art Liquid Nitrogen Blast Freezers

Posted on

Working with an OEM that offers an experimental test run of your product provides evidence-based research that a freezer fulfills your operational requirements

Pharmaceutical and medical researchers rely on blast freezers to quickly freeze drug products, active ingredients, and biospecimens to extremely low temperatures during R&D storage, transport, or manufacturing.

Today, state-of-the-art liquid nitrogen blast freezers can quick freeze products, ingredients, and specimens to ultra-low temperatures much faster and with greater control than conventional technology. However, verifying that a unit can handle specific products with the necessary speed of cooling, accuracy, and reliability is crucial prior to purchase.

To help researchers considering a blast freezer to verify that a unit meets their requirements before purchase, Reflect Scientific now offers a trial test run of its product with complete documentation of the results.

“With a test run, you can understand the process inputs and outputs required by your product and blast freezer before finalizing a purchase. You can design the test with any process requirements or restraints, and we will provide you with the results,” says Sheldon Larson, Customer/Product Engineer, Cryometrix Freezer and Chiller Products at Reflect Scientific, Inc., an OEM of cryogenic cooling technologies for the pharmaceutical, biotechnology, medical, and transportation markets.

According to Larson, the experimental test run report, conducted on a B-90 Cryometrix blast freezer with thawing capability, can help researchers determine key data such as:

  • freeze and thaw times of drug substances or drug substance substitutes;
  • estimated liquid nitrogen use during a standard designed batch freeze/thaw cycle; and
  • other items specified during the design stage of the experimental run cycle.

The Cryometrix B-90 blast freezer by Reflect Scientific utilizes safely contained liquid nitrogen at -196°C to freeze products with cooled air. The system is designed so there is no contact between the LN2 and the operator or product, which helps to ensure safety. It can cool product inside from 20°C to -90°C in less than 10 minutes. The temperature is adjustable from +40°C to -90°C, with temperature uniformity of ± 3°C throughout.

To ensure product quality, the B-90 provides state-of-the-art temperature and data logging, which can be easily accessed through a touch screen or downloaded to a computer. The latest software upgrade allows up to 250 users and 8 security levels. Managers can easily control who can open the freezer, change the setpoint, and adjust the setting.

The blast freezer also offers optional rapid thawing capability up to 40°C in the same machine. With this option, the end user does not need two separate machines but can perform both rapid freezing and thawing procedures with one unit.

According to Larson, the experimental test run report typically provides a summary of test results for the duration of freeze and/or thaw cycle, LN2 consumption for the test run, any abnormalities in testing, and suggestions for production level runs.

In addition, an outline is provided of how the test was set up. This includes the location of each thermocouple that gathered data, along with photos and video of the set up and test if desired. Raw data files of all sensors used during the test can also be provided as specified in the experimental test run design.

When researchers need to verify that a blast freezer effectively meets their needs prior to finalizing a purchase, selecting an OEM that offers an experimental test run with its product can provide the evidence-based research needed to make a fully informed buying decision.

For more information: call 801-226-4100; email info@cryometrix.com; visit www.cryometrix.com; or write to the Cryometrix brand at Reflect Scientific, Inc., 1266 South 1380 West, Orem, Utah 84058.

Ultra‐Low Temperature Freezer Offers an Alternative to Traditional Cryovats

Posted on

By Brian Buntz | January 31, 2023

Reflect Scientific’s Cryometrix T‐160 ultra‐low temperature freezer is designed to be a safer, more reliable and more efficient option for the pharmaceutical and medical industries than cryogenic freezers requiring liquid nitrogen. The refrigerator also replaces the compressor and refrigerant design present in most biorepositories.

The upright liquid nitrogen freezer boasts adjustable temperatures from +20°C to –160°C, providing faster freeze times than traditional upright freezer options. The freezer also offers temperature uniformity of ±7°C, ensuring sample preservation.

Eco‐friendly design and other features

The manufacturer notes that the Cryometrix freezer is eco‐friendly, with a simplified design and minimal moving parts. It says the design supports reliability and lowers maintenance costs. Reflect Scientific also offers a 20‐year warranty on the cooling system.

The freezer minimizes the risk of sample warming and deterioration related to door events. The temperature and data logging can be readily accessed, and multiple security levels can be set for enhanced sample protection. The redundant cooling system and onboard seven‐day battery backup ensure uninterrupted processes even during a power loss.

It also offers automatic tracking of temperature and other data.

Furthermore, the Cryometrix freezer is said to use up to 90% less energy than mechanical, compressor‐based units, lowering operating costs. The freezer also eliminates the need for expensive HVAC systems as it doesn’t emit heat into the room.

The ultra‐low temperature freezer offers a redundant emergency valve for use during a power outage to maintain the temperature in the payload bay.

Compact design

Its compact design is suitable for space‐constrained storage environments.

The ultra‐low temperature freezer measures under 8 ft2.

Reflect Scientific also offers products supporting a range of life‐science applications, including plasma freezing, CAR‐T cell storage, stem cell storage and various cGMP processes.

The company’s blast freezers can quickly freeze and thaw temperature‐sensitive materials during R&D for new

drugs, vaccines and biologics. It also supports temperature profiling, which can shed light on how products will handle temp changes during transport, storage and distribution. Blast freezers also store blood plasma, cryoprecipitate, vaccines and other substances.

About the Author: Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications.